Welcome to augmented neuroimaging
What is NEUROCLOUD?
NEUROCLOUD is advanced neuroimaging processing software. Increases diagnostic security, favors early detection and accurate monitoring of pathologies. Facilitates collaboration between teams and increases their productivity. #augmentingNeuroimages
NEUROCLOUD: Automatic. Fast. Precise.
Accelerates and improves neuroimaging analysis thanks to Neurocloud’s advanced AI-powered processing. Facilitates the detection and monitoring of neurological diseases.
Localization of abnormal areas in multimodal images (PET, SPECT, MRI).
100% automatic. Fast, intuitive and easy to use. Save time, improve your productivity.
100% compatible with your technology:
No installation needed and immediate use. Clinically validated.
RELIABLE AND IMMEDIATE RESULTS.
Calculation of biomarkers in a few minutes and immediate comparison with extensive databases of healthy controls.
CE Marking: Qubiotech is an authorized manufacturer by the AEMPS and all Neurocloud solutions are CE marked
How It Works
Neurocloud is an online platform, fast, simple and intuitive that allows the use of quantitative tools in the clinical routine in only 3 steps.
Drag and Drop
Automatic data anonymization
Identification of abnormal areas.
Results in 5 minutes.
Complete report attached to the medical history.
They are already customers
Dra. Puy Garrastachu considers that Neurocloud is a support tool in the evaluation of inconclusive PET images, being in our daily experience, useful in cases of atypical parkinsonism and dementia of difficult diagnosis.
The H. del Mar Epilepsy Unit is a European Reference Center in the diagnosis and treatment of refractory epilepsy. They have decided to use all the applications of Neurocloud since it allows them to easily integrate nuclear medicine and magnetic resonance studies and facilitate their work as a team.
Dr. Xavier Setoain, co-author of the epileptogenic focus location method implemented by Neurocloud-SISCOM, uses it routinely because of the ease of use and the confidence provided by the results it provides.
Dr. Carlos Torrijo has been using Neurocloud for years as a quantification assistant for the neurology studies he carries out with PET 18FDG. Recently he has supervised an end of course work where he has compared the diagnostic performance of Neurocloud-PET in 50 dementia patients, finding that in 38% of the cases the use of Neurocloud improved the diagnosis and the confidence of the reporting physician.